Taxis Pharmaceuticals INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersMonmouth Junction, NJ
US patents7
SAM.gov UEIC2NWS2FZS5F5
CAGE code5DMK7
Incorporated inDE
- developing investigational therapies
- combat antimicrobial resistance
- targeting
- bacterial cell division
- walls
- working
- Efflux Pump Inhibitors
- Qualified Infectious Disease Product
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2016–2024, 2 of them in the five years to SEP 2025.
Pharmaceuticals 4Organic fine chemistry 3
- Synthetic processes and synthetic intermediatesUS 12,173,013 · granted DEC 24, 2024
- Antimicrobial agentsUS 11,129,814 · granted SEP 28, 2021
- Synthetic processes and synthetic intermediatesUS 10,774,093 · granted SEP 15, 2020
- Synthetic processes and intermediatesUS 10,513,528 · granted DEC 24, 2019
- Antimicrobial agentsUS 10,071,082 · granted SEP 11, 2018
Newest 5 shown · Granted to TAXIS Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Taxis Pharmaceuticals INC | Monmouth Junction | NJ | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.